Related Experiment Video
Updated: Jun 26, 2025

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization
Guorui Zhao1, Zhe Lu1, Yundan Liao1
1Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing 100191, China.
Introduction:
Psychiatric disorders present a substantial global public health burden with limited drug options. The gut-brain axis connects inflammatory bowel diseases and psychiatric disorders, which often have comorbidities. While some evidence hints at anti-inflammatory drugs aiding in treating psychiatric conditions, the specific effects of intestinal anti-inflammatory drugs remain unclear.
Objectives:
This study investigates the causal effect of intestinal anti-inflammatory drug targets on psychiatric disorders. We hypothesize that these drug targets may offer new insights into the treatment and prevention of such disorders. Additionally, we explore gut microbiota's mediating role between drug target genes and psychiatric disorders.
Methods:
We performed two-sample Mendelian randomization (MR) using summary data from existing expression quantitative trait loci (eQTL) and protein QTL in the brain, along with public genome-wide association studies of disease. We also explored gut microbiota's mediating effect. The statistics encompassed six psychiatric disorders involving 9,725-500,199 individuals. Colocalization analysis enhanced the MR evidence.
Results:
We uncovered a causal link between TPMT (a target of olsalazine) expression in the amygdala and bipolar disorder (BD) risk (odds ratio [OR] = 1.08; P = 4.29 × 10-4). This association was observed even when the sigmoid colon and whole blood eQTL were considered as exposures. Colocalization analysis revealed a shared genetic variant (rs11751561) between TPMT expression and BD, with a posterior probability of 61.6 %. Interestingly, this causal effect was influenced by a decrease in the gut microbiota abundance of the genus Roseburia (effect proportion = 10.05 %). Moreover, elevated ACAT1 expression was associated with higher obsessive-compulsive disorder risk (OR = 1.62; P = 3.64 × 10-4; posterior probability = 3.1 %).
Conclusion:
These findings provide novel targets for the treatment of psychiatric disorders, underscore the potential of repurposing olsalazine, and emphasize the importance of TPMT and ACAT1 in future drug development.
Insights
Intestinal anti-inflammatory drug targets, like TPMT and ACAT1, show causal links to bipolar disorder and obsessive-compulsive disorder. Gut microbiota may mediate these effects, offering new therapeutic avenues for psychiatric disorders.
Area of Science:
- Neuroscience
- Genetics
- Pharmacology
Background:
- Psychiatric disorders pose a significant global health challenge with limited treatment options.
- The gut-brain axis links inflammatory bowel diseases and psychiatric disorders, suggesting shared biological pathways.
- The role of intestinal anti-inflammatory drugs in psychiatric conditions remains largely unexplored.
Purpose of the Study:
- To investigate the causal relationship between intestinal anti-inflammatory drug targets and psychiatric disorders.
- To explore the potential mediating role of gut microbiota in these associations.
- To identify novel therapeutic targets for psychiatric conditions.
Main Methods:
- Two-sample Mendelian randomization (MR) was employed using eQTL and pQTL data from brain, sigmoid colon, and whole blood.
- Genome-wide association study (GWAS) data for six psychiatric disorders were analyzed.
- Colocalization analysis and gut microbiota abundance data were used to strengthen evidence and explore mediation.
Main Results:
- A causal effect of TPMT expression in the amygdala on bipolar disorder risk was identified (OR=1.08, P=4.29×10⁻⁴).
- This association was mediated by a decrease in Roseburia gut bacteria abundance (10.05%).
- Elevated ACAT1 expression was causally linked to increased obsessive-compulsive disorder risk (OR=1.62, P=3.64×10⁻⁴).
Conclusions:
- TPMT and ACAT1 represent novel therapeutic targets for psychiatric disorders.
- Repurposing existing anti-inflammatory drugs like olsalazine may be a viable treatment strategy.
- The gut microbiota plays a significant role in the gut-brain axis and psychiatric conditions.
More Related Videos
Related Concept Videos
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...

